Musculoskeletal Pathology

Strategic objectives


  • Health Systems Research
  • Musculoskeletal disability research
  • Epidemiology of musculoskeletal diseases.
  • Exploitation of databases on disability in the active population and disability in the elderly.
  • Studies ‘in daily life’ of safety and efficacy of disease-modifying drugs.
  • Calculation of Qualys in routine rheumatology care.
  • Carry out a global programme to detect incidents and adverse events in patients with musculoskeletal pathologies.
  • Complete the development and implementation of Medi-log (electronic medical records).
  • Implementation of the information platform with shared management of samples and clinical data.


  • Mesenchymal stem cells.
  • Regenerative therapy.
  • Development of the non-commercial clinical trial for the application of MSCs in the prevention of arthropathy secondary to rotator cuff rupture.
  • Clean Room accreditation. Process accreditation


  • Deepen the genetic analysis of the pathologies described in the projects.
  • Qualitatively and quantitatively expand our bank of genetic samples.


  • Application of proteomic and massive genotyping techniques to the study of osteoarthritis, rheumatoid arthritis and mesenchymal stem cells.
  • Development of an animal model of shoulder arthropathy secondary to rotator cuff tear.
  • Study of the role of IL-6 in rheumatoid arthritis.
  • Study of the physiological and pathological characteristics of MSCs.

Lines of research

  • Inflammatory joint diseases associated with ageing Arthrosis. Cartilage/tendon/bone research.
  • Chronic inflammatory arthropathies
  • Rheumatoid arthritis
  • Mesenchymal stem cells.
  • Regenerative therapy.
  • Genetics of musculoskeletal diseases.
  • Health systems research.
  • Research in musculoskeletal disability.
  • Epidemiology of musculoskeletal diseases.


Head of research lines: Dr. Lydia Abásolo Alcazar

  • Quality of life, pain and disability in musculoskeletal diseases.
  • Clinical epidemiology in rheumatoid arthritis.
  • Clinical epidemiology in diffuse interstitial lung disease associated with autoimmune rheumatologic diseases.
  • Clinical epidemiology in giant cell arteritis.
  • Clinical epidemiology in spondyloarthropathies
  • Clinical epidemiology in COVID-19

Head of research lines: Dr. Luis Rodríguez Rodríguez

  • Intraocular Inflammation
  • Innovation and Information and Communication Technologies in Rheumatology



Other members of the group

  • María Paula Álvarez Hernández
  • Gloria Candelas Rodríguez
  • Inmaculada Chicarro Rodríguez
  • Susana Donadeu Sánchez
  • Dalifer Dayanira Freites Nuñez
  • Irene Gonzalez Guede
  • Ángeles López De Benito
  • María López Ramos
  • Cristina De Jesús Lajas Petisco
  • Leticia León Mateos
  • Yaiza Lopiz Morales
  • Alfredo Madrid García
  • Fernando Marco Martínez
  • Teresa Mulero López
  • María Asunción Nieto Barbero
  • María Dolores Olmos Gómez
  • Eduardo Ossuna Juntárez
  • Inés Pérez Sancristóbal
  • Ana María Pérez Sáez
  • Esperanza Pato Cour
  • Maria Rodero Lopez
  • María Rodríguez Mariblanca
  • Luis Rodríguez Rodríguez
  • Zulema Rosales Rosado
  • Teresa Sofía Sánchez Pascua
  • Cristina Vadillo Font